PG
EXPE icon

Prostatis Group’s Expedia Group EXPE Stock Holding History

Prostatis Group’s Portfolio EXPE Stock Details EXPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Buy
+792
New +$188K 0.05% 186

Other funds holding EXPE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $10.1B AUM 10.46% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Prostatis Group's EXPE Position: Q2 2026 in Review

Prostatis Group opened a new position in Expedia Group (EXPE) in Q2 2026: 792 shares worth $203K. The stake represents 0.05% of the portfolio and ranks #186 among its holdings.

1,122 funds tracked by Wall St. Rank hold EXPE as of Q2 2026.

  • Prostatis Group held 792 shares of Expedia Group worth $203K as of Q2 2026.
  • Expedia Group was a new Prostatis Group position in Q2 2026.
  • Expedia Group made up 0.05% of Prostatis Group's portfolio in Q2 2026, its #186 holding.
  • 1,122 funds tracked by Wall St. Rank held Expedia Group as of Q2 2026.

Based on Prostatis Group's 13F filing for Q2 2026, filed 14 Aug 2026.